XORTX Therapeutics
XRTX
3 hedge funds and large institutions have $49K invested in XORTX Therapeutics in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$57.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.09K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.03K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
CIBC World Market
Toronto,
Ontario, Canada
| $46K | +$57.6K | +56 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $2K | +$3.09K | +3 | New |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$1.03K | +1 | New |
|
XRTX Hedge Fund Activity: Q4 2021 in Review
3 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in XORTX Therapeutics (XRTX) for Q4 2021, worth a combined $49K.
Buyers outnumbered sellers: 3 funds opened new XRTX positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was CIBC World Market, opening a new position worth an estimated $57.6K.
- 3 institutional investors held XORTX Therapeutics (XRTX) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $49K of XORTX Therapeutics stock for Q4 2021.
- 3 funds opened new XORTX Therapeutics positions in Q4 2021 and 0 closed out, a net change of +3 holders.
- The largest XORTX Therapeutics buyer in Q4 2021 was CIBC World Market, an estimated $57.6K added.
Based on aggregated 13F filings for Q4 2021.